ADMA Biologics Inc. (NASDAQ:ADMA) Q1 2021 Earnings Conference Call May 12, 2021 4:30 PM ET Company Participants Skyler Bloom - IR Adam Grossman - President and CEO Brian Lenz - CFO Conference Call Participants Anthony Petrone - Jefferies Michael Parolari - Raymond James Operator Good afternoon, and welcome to ADMA Biologics First Quarter 2021 Financial Results and Corporate Update on Wednesday, May 12, 2021. At this time all participants lines are in a listen-only mode. There will be question and answer ses ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Skyler Bloom - Director, Investor Relations and Corporate Strategy Adam Grossman - Founder, President and Chief Executive Officer Brian Lenz - Executive Vice President and Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Elliot Wilbur - Raymond James Operator Good afternoon and welcome to the ADMA Biologics Fourth Quarter and Full Year 2020 Financial Results Conf ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Skyler Bloom – Director-Investor Relations and Corporate Strategy Adam Grossman – President and Chief Executive Officer Brian Lenz – Executive Vice President and Chief Financial Officer Conference Call Participants Anthony Petrone – Jefferies Elliot Wilbur – Raymond James Leland Gershell – Oppenheimer Boobalan Pachaiyappan – H. C. Wainwright Zach Weiner – Jefferies Operator Good afternoon, an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36728 ADMA BIOLOGICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 56-2590442 (Sta ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2020 Results Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Michelle Pappanastos - Investor Relations, Argot Partners Adam Grossman - Founder, President and Chief Executive Officer Brian Lenz - Executive Vice President and Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Elliot Wilbur - Raymond James Raghuram Selvaraju - H.C. Wainwright & Co. Leland Gershell - Oppenheimer & Co. Operator Good afternoon and welcome ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36728 ADMA BIOLOGICS, INC. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | |------------- ...